Epigenetics in cardiovascular disease

被引:66
|
作者
Shirodkar, Apurva V. [1 ]
Marsden, Philip A. [1 ,2 ]
机构
[1] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Med, St Michaels Hosp, Div Renal, Toronto, ON M5S 1A8, Canada
基金
加拿大健康研究院;
关键词
cardiovascular disease; DNA methylation; epigenetics; histone posttranslational modifications; NITRIC-OXIDE SYNTHASE; EMBRYONIC STEM-CELLS; CPG-BINDING-PROTEIN; ENDOTHELIAL GENE-EXPRESSION; FLUID SHEAR-STRESS; DNA METHYLATION; CHROMATIN-STRUCTURE; NONCODING RNAS; HISTONE CODE; TRANSCRIPTION;
D O I
10.1097/HCO.0b013e328345986e
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review To provide an overview of the biological processes implicated in chromatin-based pathways that control endothelial gene expression patterns in both health and disease and highlight how these processes are relevant to cardiovascular disease. Recent findings Epigenetics refers to chromatin-based pathways important in the regulation of gene expression and includes three distinct, but highly interrelated, mechanisms: DNA methylation, histone density and posttranslational modifications, and RNA-based mechanisms. It is of great interest that epigenetic regulation of genes enriched in the vascular endothelium is a prominent regulatory pathway. How environmental cues within the vasculature, such as hemodynamic forces or hypoxia, influence these epigenetic mechanisms will be reviewed. Summary Although a newer area for study, exciting new evidence identifies that epigenetic processes are highly dynamic and respond to a myriad of environmental stimuli. Integrating chromatin-based pathways into our understanding of gene expression offers newer insight into disease processes.
引用
收藏
页码:209 / 215
页数:7
相关论文
共 50 条
  • [1] Epigenetics and cardiovascular disease
    José M. Ordovás
    Caren E. Smith
    [J]. Nature Reviews Cardiology, 2010, 7 : 510 - 519
  • [2] Epigenetics and cardiovascular disease
    Delbridge, Lea M. D.
    Mellor, Kimberley M.
    Wold, Loren E.
    [J]. LIFE SCIENCES, 2015, 129 : 1 - 2
  • [3] Epigenetics and Cardiovascular Disease
    Webster, Andrew L. H.
    Yan, Matthew Shu-Ching
    Marsden, Philip A.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (01) : 46 - 57
  • [4] Epigenetics and cardiovascular disease
    Ordovas, Jose M.
    Smith, Caren E.
    [J]. NATURE REVIEWS CARDIOLOGY, 2010, 7 (09) : 510 - 519
  • [5] The impact of epigenetics on cardiovascular disease
    Prasher, Dimple
    Greenway, Steven C.
    Singh, Raja B.
    [J]. BIOCHEMISTRY AND CELL BIOLOGY, 2020, 98 (01) : 12 - 22
  • [6] Epigenetics and Cardiovascular Disease in Diabetes
    Jennifer Pasquier
    Jessica Hoarau-Véchot
    Khalid Fakhro
    Arash Rafii
    Charbel Abi Khalil
    [J]. Current Diabetes Reports, 2015, 15
  • [7] Epigenetics and Cardiovascular Disease in Diabetes
    Pasquier, Jennifer
    Hoarau-Vechot, Jessica
    Fakhro, Khalid
    Rafii, Arash
    Khalil, Charbel Abi
    [J]. CURRENT DIABETES REPORTS, 2015, 15 (12)
  • [8] Environmental exposures, epigenetics and cardiovascular disease
    Baccarelli, Andrea
    Ghosh, Sanjukta
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2012, 15 (04): : 323 - 329
  • [9] Translational Perspective on Epigenetics in Cardiovascular Disease
    van der Harst, Pim
    de Windt, Leon J.
    Chambers, John C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (05) : 590 - 606
  • [10] The genetics of epigenetics: is there a link with cardiovascular disease
    Xiao, Qingzhong
    Ye, Shu
    [J]. HEART, 2011, 97 (02) : 96 - 97